Expression of mouse mammary tumor virus superantigen mRNA in the thymus correlates with kinetics of self-reactive T-cell loss

Journal of Virology

Volumn 73, Issue 8, 1999, Pages 6634-6645

  Barnett, Anna ^a,b   Mustafa, Farah ^a   Wrona, Thomas J ^a   Lozano, Mary ^a   Dudley, Jaquelin P ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; SUPERANTIGEN; VIRUS ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELL LOSS; LYMPHOCYTE PROLIFERATION; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; THYMUS;

EID: 0032775719     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.8.6634-6645.1999     Document Type: Article

References (60)

1. f system. I. A novel "polymorphism" of endogenous superantigens. J. Immunol. 149:3429-3439.
2. Abe, R., O. Kanagawa, M. A. Sheard, B. Malissen, and M. Foo-Phillips. 1991. Characterization of a new minor lymphocyte stimulatory system. I. Cluster of self antigens recognized by "I-E-reactive" Vβs, Vβ5, Vβ11, and Vβ12 T cell receptors for antigen. J. Immunol. 147:739-749.
3. Acha-Orbea, H., W. Held, G. A. Waanders, A. N. Shakhov, L. Scarpellino, R. K. Lees, and H. R. MacDonald. 1993. Exogenous and endogenous mouse mammary tumor virus superantigens. Immunol. Rev. 131:5-25.
4. Acha-Orbea, H., and H. R. MacDonald. 1995. Superantigens of mouse mammary tumor virus. Annu. Rev. Immunol. 13:459-486.
5. Acha-Orbea, H., A. N. Shakhov, L. Scarpellino, E. Kolb, V. Muller, A. Vessaz-Shaw, R. Fuchs, K. Blochlinger, P. Rollini, J. Billotte, et al. 1991. Clonal deletion of Vβ14-bearing T cells in mice transgenic for mammary tumour virus. Nature 350:207-211.
6. Arroyo, J., E. Winchester, B. S. McLellan, and B. T. Huber. 1997. Shared promoter elements between a viral superantigen and the major histocompatibility complex class II-associated invariant chain. J. Virol. 71:1237-1245.
7. Beutner, U., E. Kraus, D. Kitamura, K. Rajewsky, and B. T. Huber. 1994. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens. J. Exp. Med. 179:1457-1466.
8. Brandt-Carlson, C., J. S. Butel, and D. Wheeler. 1993. Phylogenetic and structural analyses of MMTV LTR ORF sequences of exogenous and endogenous origins. Virology 193:171-185.
9. Chervonsky, A. V., T. V. Golovkina, S. R. Ross, and C. A. Janeway, Jr. 1995. Differences in the avidity of TCR interactions with a superantigenic ligand affect negative selection but do not allow positive selection. J. Immunol. 155:5115-5123.
10. Choi, Y., J. W. Kappler, and P. Marrack. 1991. A superantigen encoded in the open reading frame of the 3′ long terminal repeat of mouse mammary tumour virus. Nature 350:203-207.
11. Choi, Y. W., D. Henrard, I. Lee, and S. R. Ross. 1987. The mouse mammary tumor virus long terminal repeat directs expression in epithelial and lymphoid cells of different tissues in transgenic mice. J. Virol. 61:3013-3019.
12. Cohen, J. C., and H. E. Varmus. 1979. Endogenous mammary tumour virus DNA varies among wild mice and segregates during inbreeding. Nature 278:418-423.
13. Dudley, J., and R. Risser. 1984. Amplification and novel locations of endogenous mouse mammary tumor virus genomes in mouse T-cell lymphomas. J. Virol. 49:92-101.
14. Dudley, J. P. 1988. Mouse mammary tumor proviruses from a T-cell lymphoma are associated with the retroposon L1Md. J. Virol. 62:472-478.
15. Dudley, J. P., A. Arfsten, C. L. Hsu, C. Kozak, and R. Risser. 1986. Molecular cloning and characterization of mouse mammary tumor proviruses from a T-cell lymphoma. J. Virol. 57:385-388.
16. q. Eur. J. Immunol. 28: 1034-1039.
17. Dyson, P. J., A. M. Knight, S. Fairchild, E. Simpson, and K. Tomonari. 1991. Genes encoding ligands for deletion of Vβ11 T cells cosegregate with mammary tumour virus genomes. Nature 349:531-532.
18. Elliott, J. F., B. Pohajdak, D. J. Talbot, J. Shaw, and V. Paetkau. 1988. Phorbol diester-inducible, cyclosporine-suppressible transcription from a novel promoter within the mouse mammary tumor virus env gene. J. Virol. 62:1373-1380.
19. Fink, P. J., C. A. Fang, and G. L. Turk. 1994. The induction of peripheral tolerance by the chronic activation and deletion of CD4+Vβ5+ cells. J. Immunol. 152:4270-4281.
20. f-reactive T cells. J. Immunol. 149:3440-3447.
21. Frankel, W. N., C. Rudy, J. M. Coffin, and B. T. Huber. 1991. Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice. Nature 349: 526-528.
22. Gollob, K. J., and E. Palmer. 1992. Divergent viral superantigens delete Vβ5+ T lymphocytes. Proc. Natl. Acad. Sci. USA 89:5138-5141.
23. Golovkina, T. V., A. Chervonsky, J. P. Dudley, and S. R. Ross. 1992. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell 69:637-645.
24. Golovkina, T. V., O. Prakash, and S. R Ross. 1996. Endogenous mouse mammary tumor virus Mtv-17 is involved in Mtv-2-induced tumorigenesis in GR mice. Virology 218:14-22.
25. Gunzburg, W. H., F. Heinemann, S. Wintersperger, T. Miethke, H. Wagner, V. Erfle, and B. Salmons. 1993. Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat. Nature 364:154-158.
26. Held, W., A. N. Shakhov, S. Izui, G. A. Waanders, L. Scarpellino, H. R. MacDonald, and H. Acha-Orbea. 1993. Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virus. J. Exp. Med. 177:359-366.
27. a (Mtv-7). J. Exp. Med. 175:1623-1633.
28. Held, W., G. A. Waanders, A. N. Shakhov, L. Scarpellino, H. Acha-Orbea, and H. R. MacDonald. 1993. Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell 74:529-540.
29. Huber, B. T., P. N. Hsu, and N. Sutkowski. 1996. Virus-encoded superantigens. Microbiol. Rev. 60:473-482.
30. Jarvis, C. D., R. N. Germain, G. L. Hager, M. Damschroder, and L. A. Matis. 1994. Tissue-specific expression of messenger RNAs encoding endogenous viral superantigens. J. Immunol. 152:1032-1038.
31. Kang, J., E. Ido, J. Pawling, U. Beutner, B. T. Huber, and N. Hozumi. 1994. Expression of Mtv-7 sag gene in vivo using a retroviral vector results in selective inactivation of superantigen reactive T cells. J. Immunol. 152:1039-1046.
32. Karapetian, O., A. N. Shakhov, J. P. Kraehenbuhl, and H. Acha-Orbea. 1994. Retroviral infection of neonatal Peyer's patch lymphocytes: the mouse mammary tumor virus model. J. Exp. Med. 180:1511-1516.
33. Korman, A. J., P. Bourgarel, T. Meo, and G. E. Rieckhof. 1992. The mouse mammary tumour virus long terminal repeat encodes a type II transmembrane glycoprotein. EMBO J. 11:1901-1905.
34. Kuo, W. L., L. R. Vilander, M. Huang, and D. O. Peterson. 1988. A transcriptionally defective long terminal repeat within an endogenous copy of mouse mammary tumor virus proviral DNA. J. Virol. 62:2394-2402.
35. Lund, F. E., T. D. Randall, D. L. Woodland, and R. B. Corley. 1993. MHC class II limits the functional expression of endogenous superantigens in B cells. J. Immunol. 150:78-86.
36. Marrack, P., E. Kushnir, and J. Kappler. 1991. A maternally inherited superantigen encoded by a mammary tumour virus. Nature 349:524-526.
37. Marrack, P., G. M. Winslow, Y. Choi, M. Scherer, A. Pullen, J. White, and J. W. Kappler. 1993. The bacterial and mouse mammary tumor virus superantigens; two different families of proteins with the same functions. Immunol. Rev. 131:79-92.
38. McMahon, C. W., B. Traxler, M. E. Grigg, and A. M. Pullen. 1998. Transposon-mediated random insertions and site-directed mutagenesis prevent the trafficking of a mouse mammary tumor virus superantigen. Virology 243:354-365.
39. Moore, N. C., G. Anderson, D. E. McLoughlin, J. J. Owen, and E. J. Jenkinson. 1994. Differential expression of Mtv loci in MHC class II-positive thymic stromal cells. J. Immunol. 152:4826-4831.
40. Morishima, C., C. Norby-Slycord, K. R. McConnell, R. J. Finch, A. J. Nelson, A. G. Farr, and A. M. Pullen. 1994. Expression of two structurally identical viral superantigens results in thymic elimination at distinct developmental stages. J. Immunol. 153:5091-5103.
41. Palmiter, R. D. 1974. Magnesium precipitation of ribonucleoprotein complexes. Expedient techniques for the isolation of undergraded polysomes and messenger ribonucleic acid. Biochemistry 13:3606-3615.
42. Picker, L. J., and M. H. Siegelman. 1993. Lymphoid tissues and organs, p. 145-197. In W. E. Paul (ed.), Fundamental immunology. Raven Press, New York, N.Y.
43. Scherer, M. T., L. Ignatowicz, A. Pullen, J. Kappler, and P. Marrack. 1995. The use of mammary tumor virus (Mtv)-negative and single-Mtv mice to evaluate the effects of endogenous viral superantigens on the T cell repertoire. J. Exp. Med. 182:1493-1504.
44. Simpson, E., P. J. Dyson, A. M. Knight, P. J. Robinson, J. I. Elliott, and D. M. Altmann. 1993. T-cell receptor repertoire selection by mouse mammary tumor viruses and MHC molecules. Immunol. Rev. 131:93-115.
45. Subramanyam, M., N. Mohan, D. Mottershead, U. Beutner, B. McLellan, E. Kraus, and B. T. Huber. 1993. Mls-I superantigen: molecular characterization and functional analysis. Immunol. Rev. 131:117-130.
46. Vacchio, M. S., J. J. Ryan, and R. J. Hodes. 1990. Characterization of the ligand(s) responsible for negative selection of Vβ11- and Vβ12-expressing T cells: effects of a new Mls determinant. J. Exp. Med. 172:807-813.
47. van Ooyen, A. J., R. J. Michalides, and R. Nusse. 1983. Structural analysis of a 1.7-kilobase mouse mammary tumor virus-specific RNA. J. Virol. 46:362-370.
48. Waanders, G. A., R. K. Lees, W. Held, and H. R. MacDonald. 1995. Quantitation of endogenous mouse mammary tumor virus superantigen expression by lymphocyte subsets. Eur. J. Immunol. 25:2632-2637.
49. Waanders, G. A., A. N. Shakhov, W. Held, O. Karapetian, H. Acha-Orbea, and H. R. MacDonald. 1993. Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus. J. Exp. Med. 177:1359-1366.
50. Weber, G. F., S. Abromson-Leeman, and H. Cantor. 1995. A signaling pathway coupled to T cell receptor ligation by MMTV superantigen leading to transient activation and programmed cell death. Immunity 2:363-372.
51. Wheeler, D. A., J. S. Butel, D. Medina, R. D. Cardiff, and G. L. Hager. 1983. Transcription of mouse mammary tumor virus: identification of a candidate mRNA for the long terminal repeat gene product. J. Virol. 46:42-49.
52. Woodland, D. L., M. P. Happ, K. J. Gollob, and E. Palmer. 1991. An endogenous retrovirus mediating deletion of αβ T cells? Nature 349:529-530.
53. Wrona, T., and J. P. Dudley. 1996. Major histocompatibility complex class II I-E-independent transmission of C3H mouse mammary tumor virus. J. Virol. 70:1246-1249.
54. Wrona, T. J., M. Lozano, A. A. Binhazim, and J. P. Dudley. 1998. Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen. J. Virol. 72:4746-4755.
55. Xu, L., T. J. Wrona, and J. P. Dudley. 1996. Exogenous mouse mammary tumor virus (MMTV) infection induces endogenous MMTV sag expression. Virology 215:113-123.
56. Xu, L., T. J. Wrona, and J. P. Dudley. 1997. Strain-specific expression of spliced MMTV RNAs containing the superantigen gene. Virology 236:54-65.
57. Yang, J. N., R. T. Boyd, P. D. Gottlieb, and J. P. Dudley. 1987. The endogenous retrovirus Mtv-8 on mouse chromosome 6 maps near several kappa light chain markers. Immunogenetics 25:222-227.
58. Yang, J. N., and J. Dudley. 1992. Endogenous Mtv-8 or a closely linked sequence stimulates rearrangement of the downstream Vκ9 gene. J. Immunol. 149:1242-1251.
59. Yang, J.-N., and J. Dudley. Unpublished data.
60. Yazdanbakhsh, K., C. G. Park, G. M. Winslow, and Y. Choi. 1993. Direct evidence for the role of COOH terminus of mouse mammary tumor virus superantigen in determining T cell receptor Vβ specificity. J. Exp. Med. 178:737-741.